Serum and CSF Biomarkers Predict Active Early Cognitive Decline Rather Than Established Cognitive Impairment at the Moment of RRMS Diagnosis
<b>(1) Background</b>: Cognitive impairment (CI) begins early in the evolution of multiple sclerosis (MS) but may only become obvious in the later stages of the disease. Little data is available regarding predictive biomarkers for early, active cognitive decline in relapse remitting MS (...
| Үндсэн зохиолчид: | , , , , , |
|---|---|
| Формат: | Өгүүллэг |
| Хэл сонгох: | English |
| Хэвлэсэн: |
MDPI AG
2022-10-01
|
| Цуврал: | Diagnostics |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://www.mdpi.com/2075-4418/12/11/2571 |